Showing 7761-7770 of 18618 results for "".
Advancing MS Care: Evolving Treatments and High-Efficacy Approaches
https://reachmd.com/programs/neurofrontiers/program-name/36356/Multiple sclerosis (MS) treatment has transformed dramatically, with a wide range of high-efficacy options currently available. Dr. Marisa McGinley, a neurologist at the Cleveland Clinic, explores how advancements in drug availability, administration methods, and efficacy are reshaping care, with aHow Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
https://reachmd.com/programs/eye-on-ocular-health/anti-vegf-vs-steroids-retinal-vein-occlusion/54483/Macular edema remains a leading cause of vision loss in retinal vein occlusion—but which therapy truly delivers the best balance of benefit and risk? In this AudioAbstract, Ryan Quigley discusses a January 2026 Frontiers in Medicine meta-analysis comparing anti-VEGF monotherapy, steroid monotherapyHow ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/ctdna-liquid-biopsy-breast-cancer-progression/48711/From real-time treatment decisions to the promise of minimal residual disease (MRD) detection, circulating tumor DNA (ctDNA) and liquid biopsy are transforming metastatic breast cancer care. In this expert-led discussion, Ashley Baker sits down with Dr. Nicholas McAndrew, a hematologist-oncologist aAdvancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
https://reachmd.com/programs/project-oncology/advancing-endometrial-cancer-care-with-adcs-and-biomarker-based-therapies/36393/Our treatment approach for patients with endometrial cancer is evolving, with antibody-drug conjugates (ADCs) and biomarker-driven therapies showing promise. Dr. Brian Slomovitz highlights future directions that could redefine treatment pathways for patients with advanced or recurrent disease.Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
https://reachmd.com/programs/clinicians-roundtable/colorectal-cancer-screening-evaluating-the-cost-effectiveness-of-noninvasive-options/33058/Colorectal cancer screening strategies have significantly evolved in recent years, with noninvasive options like stool and blood-based tests explored for their potential to boost adherence. Drs. Gloria Coronado and Carolyn Rutter join Dr. Brian McDonough to evaluate how these methods compare to tradThe Dermatology and Aesthetics Mergers and Acquisitions Market: Reflecting on Trends, Looking ahead
https://modernaesthetics.com/ma-issues-index/2025-mar-apr/the-dermatology-and-aesthetics-mergers-and-acquisitions-market-reflecting-on-trends-looking-ahead/36070/As we look ahead to 2025, dermatology and aesthetic practice owners are asking a key question: What lies ahead for practice valuations and M&A opportunities?Understanding Pain Management in Children with Neurological Disorders
https://reachmd.com/programs/neurofrontiers/understanding-pain-management-in-children-with-neurological-disorders/16068/Find out how to best understand and treat pain in children with neurological disorders.Navigating the Crisis: How to Diagnose and Treat Malignant Hyperthermia
https://reachmd.com/programs/clinicians-roundtable/navigating-the-crisis-how-to-diagnose-and-treat-malignant-hyperthermia/18111/Here’s what you need to know about diagnosing and treating malignancy hyperthermia.From Pathophysiology to Therapeutic Progress: TYK2's Significance in Plaque Psoriasis
https://reachmd.com/programs/spotlight-psoriasis/from-pathophysiology-to-therapeutic-progress-tyk2s-significance-in-plaque-psoriasis/15835/How can our understanding of TYK2 help us better treat our patients with moderate-to-severe plaque psoriasis? Join us to find out.Paraneoplastic Encephalitis: How This New Discovery Relates to Testicular Cancer
https://reachmd.com/programs/advanced-treatments-innovations-mayo-clinic/paraneoplastic-encephalitis-how-new-discovery-relates-testicular-cancer/11130/Why might severe neurological symptoms be associated with testicular cancer? Take a deep dive into the research that may have found the answer.